ArticleThe Pan African medical journal2024
Ten-year review of ST-Segment Elevation Myocardial Infarction (STEMI) in Tanzania: a single center retrospective review.
Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Characteristics and risk factors for mortality in patients with acute coronary syndrome concomitant sepsis: a retrospective multicenter cohort study.Frontiers in cardiovascular medicine · 2025Article
- Effectiveness and medication adherence in patients with ST- elevated myocardial infarction: Persian polypill study.ARYA atherosclerosis · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ischemic Heart Disease (IHD) is an emerging epidemic in sub-Saharan Africa (SSA). Although the true burden may be underreported in the African continent, it still remains one of the leading causes of death among adults aged above 60 years. ST-Segment Elevation Myocardial Infarction (STEMI) is a clinically time-sensitive fatal sequela of IHD with timely reperfusion by primary Percutaneous Coronary Intervention (PCI) being the gold standard of care. There has been steady progress in coronary care services in Tanzania, alongside a rise in IHD-related risk factors. However, data on this is limited. This study aimed to examine trends in STEMI over the past decade and identify factors associated to in-hospital mortality. Methods: this single-center retrospective study was conducted at the Aga Khan Hospital Dar-es-Salaam (AKHD), Tanzania. The AKHD is one of the pioneers in establishing the first cardiac catheterization laboratory in the nation. The current study involved extracting relevant data of all patients who presented with STEMI from August 2014 to December 2023. Descriptive statistics were used to define the population. Patient´s outcomes were based on hospital survival. Binary logistic regression was run (at 95% CI and p-value<0.05) to identify the determinants for in-hospital mortality. Results: two hundred and thirty (n=230) patients were included in the final analysis. The cohort was predominantly male (83.5%, n=192), with a median age of 55.0 years (IQR 48.0-65.0). More than half of the cohort were patients with Diabetes (56.9%, n=131) and hypertension (51.6%, n=111), presenting in Killip class I symptoms (54.3%, n=125). Most patients presented with chest pain (n=162,72.6%), with a median duration of 12.2 hours (IQR 3.0-24.0 hours). The left anterior descending (LAD) artery was the culprit vessel in most cases (48.7%, n=112). A total of 163 (70.8%) patients underwent Primary-PCI. A mean BMI above 36.2 kg/m Conclusion: the in-hospital mortality among patients with STEMI at our hospital was 5.7%. Cigarette smoking, obesity and the need for mechanical ventilation were predictors of poor in-hospital outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.